Chemours Announces Management Actions and Delay of Form 10-K

Chemours Announces Management Actions and Delay of Form 10-K; Provides Preliminary Unaudited 2023 Year-End Results

The Board of Directors of The Chemours Company has appointed Denise Dignam as the Interim Chief Executive Officer and Matt Abbott as the Interim Chief Financial Officer .


Ms. Dignam joined...

Related Keywords

United States , Delaware , American , Mark Newman , Matt Abbott , Camela Wisel , Denise Dignam , Dupont De Nemours Inc , Chemours Company , Specialized Solutions , Securities Exchange , Eidp Inc , Partner At Pricewaterhousecoopers , Audit Committee , Engineering Technology , Information Technology , Exchange Commission , Audit Committee Of The Board Directors , Linkedin , Corteva Inc , Interim Chief Executive Officer , Interim Chief Financial Officer , Titanium Technologies , Advanced Performance Materials , Vice President , Global Operations , Global Senior Business Director , North American Business Director , Diversified Technologies , Industrial Resins , Pont De Nemours , Global Supply Chain , Global Business Manager , Sulfur Products , Global Sales Manager , Clean Technologies , Senior Vice President , Chief Enterprise Transformation Officer , Enterprise Capital Projects , Cyber Security , Data Analytics , Chemour Vice President , Data Analytics Leader , Chief Accounting Officer , Chief Audit Executive , Dawn Farrell , Net Sales , Chief Executive Officer Mark Newman , Chief Financial Officer Jonathan Lock , Principal Accounting Officer Camela Wisel , Chemours Ethics Hotline , Annual Report , Preliminary Year End Results , Advanced Performance Material Materials , Glycolic Acid , Dupont De Nemours , Securities Act , Securities Exchange Act , Quarterly Report ,

© 2025 Vimarsana